HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Failure of mefloquine therapy in progressive multifocal leukoencephalopathy: report of two Japanese patients without human immunodeficiency virus infection.

Abstract
Although progressive multifocal leukoencephalopathy (PML) cases showing responses to mefloquine therapy have been reported, the efficacy of mefloquine for PML remains unclear. We report on the failure of mefloquine therapy in two Japanese patients with PML unrelated to human immunodeficiency virus. One of the patients was a 47-year-old male who had been treated with chemotherapy for Waldenström macroglobulinemia, and the other was an 81-year-old male with idiopathic CD4(+) lymphocytopenia. Diagnosis of PML was established based on MRI findings and increased JC virus DNA in the cerebrospinal fluid in both patients. Mefloquine was initiated about 5 months and 2 months after the onset of PML, respectively. During mefloquine therapy, clinical and radiological progression was observed, and JC virus DNA in the cerebrospinal fluid was increased in both patients. Both patients died about 4 months and 2 months after initiation of mefloquine, respectively. Further studies are necessary to clarify the differences between mefloquine responders and non-responders in PML.
AuthorsZen Kobayashi, Miho Akaza, Yoshiyuki Numasawa, Shoichiro Ishihara, Hiroyuki Tomimitsu, Kazuo Nakamichi, Masayuki Saijo, Tomohiro Morio, Norio Shimizu, Nobuo Sanjo, Shuzo Shintani, Hidehiro Mizusawa
JournalJournal of the neurological sciences (J Neurol Sci) Vol. 324 Issue 1-2 Pg. 190-4 (Jan 15 2013) ISSN: 1878-5883 [Electronic] Netherlands
PMID23182496 (Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2012 Elsevier B.V. All rights reserved.
Chemical References
  • Antibodies, Monoclonal, Murine-Derived
  • DNA, Viral
  • Immunosuppressive Agents
  • Rituximab
  • Mefloquine
Topics
  • Aged, 80 and over
  • Antibodies, Monoclonal, Murine-Derived (therapeutic use)
  • Apraxias (etiology)
  • Asian People
  • Brain (pathology)
  • DNA, Viral (genetics)
  • Gait Disorders, Neurologic (etiology)
  • Gene Dosage
  • Humans
  • Immunosuppressive Agents (therapeutic use)
  • JC Virus
  • Leukoencephalopathy, Progressive Multifocal (drug therapy, virology)
  • Magnetic Resonance Imaging
  • Male
  • Mefloquine (therapeutic use)
  • Middle Aged
  • Muscle Cramp (etiology)
  • Paresis (etiology)
  • Rituximab
  • Treatment Failure

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: